Treating Paget's disease.

This publication has 21 references indexed in Scilit:

• Low dose intravenous 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (APD) for the treatment of Paget's disease of bone.
  Annals of the Rheumatic Diseases, 1986
• Effective short term treatment of Paget's disease with oral etidronate.
  BMJ, 1986
• INTRAVENOUS CLODRONATE IN THE TREATMENT AND RETREATMENT OF PAGET'S DISEASE OF BONE
  The Lancet, 1985
• Efficacy of the bisphosphonate APD∗∗(Note on the nomenclature: Traditional abbreviations for identifying compounds have been used in the text. According to IUPAC: Nomenclature of Organic Chemistry, Sections A-H (Pergamon Press, Oxford, 1979), the new abbreviations are as follows: APD = AHP1BP: 3-amino-1-hydroxypropylidene-1,1-bisphosphonate EHDP = HEBP: 1-hydroxyethylidene-1,1-bisphosphonate Cl2MDP = Cl2MBP: Dichloromethylenebisphosphonate. in the control of Paget's bone disease
  Bone, 1985
• Clinical experience with the use of two diphosphonates in the treatment of Paget's disease.
  Annals of the Rheumatic Diseases, 1985
• FOCAL OSTEOMALACIA DUE TO LOW-DOSE DIPHOSPHONATE THERAPY IN PAGET'S DISEASE
  The Lancet, 1984
• PATHOLOGIC FRACTURE DUE TO SEVERE OSTEOMALACIA FOLLOWING LOW‐DOSE DIPHOSPHONATE TREATMENT OF PAGET'S DISEASE OF BONE
  Australian and New Zealand Journal of Medicine, 1983
• Review of Fracture Experience During Treatment of Paget??s Disease of Bone with Etidronate Disodium (EHDP)
  Published by Wolters Kluwer Health ,1983
• Paget's disease of bone: the Lancashire focus.
  BMJ, 1980
• PAGET'S BONE DISEASE TREATED WITH DIPHOSPHONATE AND CALCITONIN
  The Lancet, 1976